<GlossaryTerm id="CDR0000803953"><TermName>Tepmetko</TermName><TermPronunciation>(tep-MET-koh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and has a certain mutation (change) in the <GeneName>MET</GeneName> gene. It is also being studied in the treatment of other types of cancer. Tepmetko blocks a protein made by the <GeneName>MET</GeneName> gene, which may help keep cancer cells from growing and spreading and may kill them. It is a type of tyrosine kinase inhibitor. Also called tepotinib hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000805381" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tepmetko&quot;" language="en" id="_3"/><MediaLink ref="CDR0000805382" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tepmetko&quot;" language="es" id="_4"/><SpanishTermName>Tepmetko</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de adultos con cáncer de pulmón de células no pequeñas que se diseminó a otras partes del cuerpo y que tiene cierta mutación (cambio) en el gen <GeneName>MET</GeneName>. También está en estudio para el tratamiento de otros tipos de cáncer. Tepmetko bloquea una proteína que se origina del gen <GeneName>MET</GeneName>, lo que quizás ayude a evitar que las células cancerosas se multipliquen y diseminen, y es posible que las destruya. Es un tipo de inhibidor de tirosina–cinasas. También se llama clorhidrato de tepotinib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2021-02-04</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000803954" url="/about-cancer/treatment/drugs/tepotinibhydrochloride">Tepotinib Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
